Skip to content

Laser-assisted exercise for adolescent with patellofemoral pain syndrome

Synergetic effects of low-energy laser and exercise on pain, kinesophobia, disability, and quality of life in adolescents with patellofemoral pain syndrome: A randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN78783043
Enrollment
64
Registered
2025-11-25
Start date
2022-08-28
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome Musculoskeletal Diseases

Interventions

This investigation recruited 64 children with a confirmed patellofemoral pain syndrome. Randomization Method: The study employed stratified randomization method to balance the study groups. Four hom
received exercise only Participants in both groups performed a standardized 35-minute core exercise program focused on lower limb strengthening, flexibility, and balance/proprioceptive training. Each

Sponsors

Prince Sattam Bin Abdulaziz University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Age of 10-18 years 2. Verified diagnosis of patellofemoral pain syndrome based on the ICD classification system (ICD-10 code for PFPS: M22.2X9) 3. Pain more than 3 on (0-10 pain scale). 4. Persistent pain more than 3 months 5. Pain get worse with activities and get better with rest.

Exclusion criteria

Exclusion criteria: 1. History of knee surgery 2. Recent trauma 3. Corticosteroids or anti-inflammatory medications in the past 6 months 4. Patellar subluxation or dislocation 5. Contraindications to low-energy laser therapy (e.g., local infection, malignancy, photosensitizing drug use)

Countries

Saudi Arabia

Contacts

Public ContactRagab Elnaggar
r.elnaggar@psau.edu.sa+96611588631

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026